Navigation Links
InVitria's Better Ingredients for Better Media to be Showcased at BPI '09
Date:10/1/2009

InVitria's new cell culture media supplements, Zap-CHO and Optiferrin, have been developed to maximize cell culture media performance and will be on display at BioProcess International '09, the premier event for the bioprocessing industry, October 12-16 at Raleigh Convention Center in Raleigh, North Carolina.

Fort Collins, CO (PRWEB) October 1, 2009 -- As conference exhibitor and poster presenter, InVitria will highlight the recent launch of two new products -- Zap-CHO and Optiferrin. These products add to InVitria's product line and will be part of its "Better Ingredients for Better Media" promotion at BPI '09.

InVitria's media supplements are gaining significant traction in the cell culture media and biomanufacturing industry and will be on display at BioProcess International Conference and Exhibition in Raleigh, North Carolina, October 12-16.

Further, InVitria will be hosting a pizza party where attendees can learn more about InVitria's completely animal free and high performance product line. Visitors to InVitria's exhibit booth #1011 can pick up an invitation to the pizza party and learn more about InVitria's exciting product line.

Zap-CHO
Zap-CHO is a defined and animal free CHO (Chinese hamster ovaries) cell culture supplement capable of replacing fetal bovine serum (FBS) while still maintaining maximum cell performance. Zap-CHO is also an alternative to using hydrolysates in cell culture media optimization because it is a well-defined supplement which reduces variability and production failures. Zap-CHO is ideal for use with commercial, chemically-defined and serum- and animal free cell culture media formulations.

Optiferrin
Optiferrin is a cell culture media supplement which supports cell growth by regulating the amount of iron transported to the cell. Since iron is required for healthy cell culture performance, it is a critical component to reach optimal performance. InVitria's Optiferrin is animal free, so it is a safe and effective alternative to using iron chelators and elemental iron in media formulations. InVitria customers have utilized Optiferrin to provide the essential amount of iron for optimal results.

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's newest products, Zap-CHO and Optiferrin, and to order InVitria products please contact InVitria at info(at)invitria(dot)com or call 1-800-916-8311. Orders may be placed online using a credit card at www.InVitria.com.

###

Read the full story at http://www.prweb.com/releases/Zap-CHO/Optiferrin/prweb2974734.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
2. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
3. Older Women May Sleep Better Than Men
4. Study shows that elderly women sleep better than they think, men sleep worse
5. Pelosi: Health Reform Will Provide Seniors Better Benefits, Guaranteed Access to Doctors, Extended Stability for Medicare
6. Chronic pain treatments work better together, says anesthesiologist
7. Henry Ford Macomb Hospital Deploys PerfectServe at Warren Campus to Improve Communication, Better Coordinate Care
8. Sexually satisfied women have better general well-being and more vitality
9. Women fare better than men with metastatic colorectal cancer -- are hormones helping?
10. UNC expert: Better decision support tools needed for prostate cancer screening choice
11. Drug-eluting stents better than bare-metal stents for heart attack patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: